𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report

✍ Scribed by Goldman, Stanton; Smith, Lynette; Galardy, Paul; Perkins, Sherrie L.; Frazer, John Kimble; Sanger, Warren; Anderson, James R.; Gross, Thomas G.; Weinstein, Howard; Harrison, Lauren; Shiramizu, Bruce; Barth, Matthew; Cairo, Mitchell S.

Book ID
125828692
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
230 KB
Volume
167
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 2 study of temozolomide in childre
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors : A report from the Children's Oncology Group
✍ H. Stacy Nicholson; Cynthia S. Kretschmar; Mark Krailo; Mark Bernstein; Richard πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. ## METHODS. Temozolomide was ad

Outcomes after HLA-matched sibling trans
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research
✍ Eapen, M; Zhang, M-J; Devidas, M; Raetz, E; Barredo, J C; Ritchey, A K; Godder, πŸ“‚ Article πŸ“… 2007 πŸ› Nature Publishing Group 🌐 English βš– 179 KB